ZELDA
DEAD

Serial Number

79268101

Owner

Zelira Therapeutics Limited

Filing Date

Jul 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ZELDA Trademark

Serial Number: 79268101

ZELDA is a trademark filed by Zelira Therapeutics Limited on July 29, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Zelira Therapeutics Limited (8 trademarks)

Level 26, 140 St Georges Terrace
Perth WA6000 , AU

Entity Type: 99

Trademark Details

Filing Date

July 29, 2019

Registration Date

Not Registered

Goods & Services

Medical cannabis and derivatives thereof; preparations for medical purposes derived from cannabis; therapeutic agents (medical); therapeutic creams (medical); therapeutic drugs (medical); natural healthcare preparations (medicaments); natural oils (medicinal); natural pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical preparations; pharmaceutical preparations for human use; medical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for topical use; pharmaceutical preparations and substances for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, alzheimer's, depression, autism and post-traumatic stress disorder; pain killers (pharmaceuticals); pharmaceutical preparations in the form of foams, gels, emulsions, elixirs, lotions, ointments, tinctures, creams, liquids, oils, lozenges, tablets, capsules, sprays and skin patches; analgesic preparations; antibacterial preparations; medical products; medicinal plants and herbs; medicinal oils; herbal preparations for medical purposes; plant extracts for medical use; plant extracts for pharmaceutical use; preparations for medical purposes

Clinical trials; project management and planning of clinical trials; conducting clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; research and development of medicinal marijuana and cannabis products; medical research; medical research (scientific research for medical purposes); scientific research; research relating to science; provision of medical research services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 24, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 24, 2022 FICR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 24, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 24, 2021 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 20, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 3, 2021 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 2, 2021 NREP
REFUSAL PROCESSED BY IB
Oct 3, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 7, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 3, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 5, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 4, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 4, 2020 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 22, 2020 ADCH
ASSIGNED TO EXAMINER
Oct 20, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 8, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 26, 2019 REPR